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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not “Does the
Use of Aromatherapy Massage Reduce Agitation in Elderly Patients with Dementia?”
Study Design: A systematic review of two randomized controlled trials (RCTs), and one cohort
study published between 2010 and 2020.
Data Sources: All studies were discovered using PubMed. The articles were published in
English in peer-reviewed journals and selected based on relevance to the clinical question.
Outcome Measured: The outcome measured was a reduction in agitation symptoms. Outcomes
were measured through the Cohen-Mansfield Agitation Inventory (CMAI). A similar scale was
used among all articles, with minimal differences. In Yang et al., a Chinese version of CMAI
was used. Fu et al. utilized a short form of CMAI. Lastly, Yoshiyama et al. used the original
CMAI. Traditionally scored out of 203 points, comprised of 29 items rated on a 7-point Likert
scale.
Results: In the cohort study by Yang et al., aromatherapy led to a reduction in agitation
symptoms compared to the other nonpharmacologic intervention (P<0.001), indicated by a mean
standard deviation change of 6.3. In the RCT crossover study by Yoshiyama et al., there was no
significant change before versus after the trial indicated by a p-value of .75 in CMAI subsection
‘complaining’, and p-value of .5 in CMAI subsection ‘repetitious mannerisms’. In RCT led by
Fu et al., subscales of the CMAI showed some reduction in agitation, however, was not
statistically significant.
Conclusion: All three studies in this review demonstrated that while there may be benefit to the
addition of aromatherapy massage in the treatment plan for certain elderly individuals with
dementia, there was no strong statistical evidence to conclude a reduction in agitation symptoms
with the use of aromatherapy massage compared to placebo. However, when compared to other
nonpharmacologic intervention there was a statistically significant reduction in symptoms of
agitation. Further studies should utilize stricter parameters in study design to evaluate the benefit
of this specific therapeutic intervention.
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INTRODUCTION
Dementia is not a specific disease process, it is a syndrome of a constellation of
symptoms that involve impaired memory, cognition and decision making that interfere with an
individual’s ability to perform activities of daily living.1 In addition to a decline in cognition,
patients experience emotional and behavioral disturbances termed behavioral and psychological
symptoms of dementia (BPSD).2 Agitation is a common symptom of dementia with 85% of
individuals affected over a five year period.3 Agitation causes physical and emotional strain
among healthcare professionals caring for patients with dementia.3 While there is not an exact
estimate of healthcare visits per year, dementia requires the use of a number of resources
including direct and indirect care. Direct care includes the use of skilled nursing facilities,
hospice, and home healthcare. Indirect care includes quality of life improvements.4
Patients with dementia are usually elderly, but cognitive impairment is not a normal
process of aging.1 It is estimated that 46.8 million people worldwide have a diagnosis of
dementia, and the number is expected to increase to 74.7 million by 2030.3 As the population
continues to age, the cost associated with care of dementia patients, specifically Alzheimer’s
Disease will rise. In 2020, it is expected that the cost of care will be $305 billion dollars.
Medicare and Medicaid cover approximately $206 billion, leaving an estimated patient out of
pocket expense of $66 billion, with an additional $33 billion in other fees.4
Dementia is a chronic progressive neurodegenerative disorder that leads to cognitive
dysfunction as well as emotional and behavioral disturbances.3 There are a number of different
causes of dementia which can be evaluated though blood tests, physical exam and
neuroimaging.1 Alzheimer’s Dementia is the most common cause of dementia.1 Other causes of
dementia include vascular dementia, Lewy body dementia, and frontotemporal dementia.
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Neurodegenerative dementias like Alzheimer’s disease have no cure, but research is ongoing to
understand treatment options for the disease.1 Current treatment modalities have a multifaceted
approach to include pharmacologic and nonpharmacologic interventions. Pharmacologic options
include antidepressants such as sertraline, antipsychotics such as olanzapine, anxiolytics such as
lorazepam, hypnotics such as zolpidem, antidementia drugs such as donepezil, and memantine.
Nonpharmacologic modalities utilize physical restraints, cognitive stimulation therapy, and
reminiscence therapy. The current medications used have adverse side effects that reduce the
quality of life for elderly patients. The pharmacologic treatments mentioned can lead to sedation
increasing the risk of falls. The method of treatment being proposed is a nonpharmacologic way
of reducing agitation in elderly patients with dementia. Aromatherapy massage can offer
additional benefits besides reduction in agitation as it is thought to increase oxygenation and
flow of nutrients to cells and tissues as well as releasing endorphins to cause relaxation 5 without
the undesirable side effects medications can cause. This paper evaluates two RCTs and one
cohort study assessing the patient response to aromatherapy massage in reducing agitation in
patients with dementia.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not “Does the Use
of Aromatherapy Massage Reduce Agitation in Elderly Patients with Dementia?”
METHODS
Studies were chosen based on relevance to the clinical question, credibility and focus on
patient oriented outcomes. All studies were selected within parameters regarding population,
intervention, comparison, and outcomes measured. The studies in this review were found in
PubMed using keywords “aroma-massage”, “dementia” and “massage therapy”. Strict

FRINZI AROMATHERAPY MASSAGE

3

parameters were put in place to select the three studies reviewed in this paper. Studies were
either RCTs or clinical trials in the English language published in peer-reviewed journals from
2010-2020. Exclusion criteria eliminated non-peer reviewed studies, systematic reviews,
metanalysis, and the population of adults under 60 years old. The selected studies utilized a pvalue to determine statistical significance, as well as change in mean standard deviation of the
Cohen-Mansfield Agitation Inventory (CMAI).
This selective EBM review focuses on the population of elderly individuals with
dementia. The demographics including exclusion and inclusion criteria are presented in Table 1.
The intervention used in each study was aromatherapy massage, while the comparison varied
among studies. Author Yang et al. compared aromatherapy massage to reminiscence therapy in a
cohort study. RCT studies by Fu et al. and Yoshiyama et al. used a placebo for comparison. The
outcome measured was a reduction in agitation symptoms evaluated through the CMAI.
OUTCOME MEASURED
All three studies utilized different adaptations of the Cohen-Mansfield Agitation
Inventory. The CMAI is a validated tool utilized by caregivers to assess the frequency of agitated
behavioral symptoms.2 The study authored by Fu et al. used the short form of the CMAI in
which 14 items are scored on a five point frequency scale, from 1 “never”, to 5 “a few times an
hour or continuing for half an hour or more”.6 Assessment was conducted at 5 points throughout
the study. The traditional version was employed in the RCT by Yoshiyama et al. consisting of a
29-item scale rated by a caregiver on frequency of agitative behaviors in the past two weeks.7
The traditional CMAI is rated on a 7-point scale ranging from “never” to “several times an hour”
with higher scores indicative of agitated behavior.7 Yoshiyama et al. conducted the CMAI
before, during, after and 4 weeks post study. Lastly, the study by Yang et al. measured outcomes

FRINZI AROMATHERAPY MASSAGE

4

both pre- and post-study using a Chinese version of the traditional CMAI. The outcomes were
measured by reduction in symptoms of agitation indicated by a decrease in CMAI score.
Table 1. Demographics and Characteristics of Included Studies
Study

Type

# Pts

Age
(yrs)
65 or
older

Yoshiyama2
(2015)

RCT

14

Yang5
(2016)

Cohort

102

83.3
mean

Fu6
(2013)

RCT

67

60 or
older

Inclusion Criteria
Residence in
nursing home,
dementia
diagnosis from
International
Classification of
Diseases, MMSE
score of 10-26,
score III on
independence
degree of daily
living, no allergic
reaction to oil,
consent
Long term care
residents with
mild-severe
dementia with
score <8 on
mental status
questionnaire or
MMSE score of
10-24
Diagnosis of
dementia with
MMSE score <24,
and features of
AD, a history of
disruptive
behavior for 2
weeks, required
chemical or
physical restraint
for agitation,
living in
participating
nursing home for
3 mo, consent,
no allergies to
aromatherapy, no
recent skin
abnormalities

Exclusion
Criteria
Acute physical
illness

W/
D
2

Interventions

Severe
behavior
prohibiting
interaction with
researcher/
participants,
psychologic
disorders

2

Reminiscence
therapy vs.
aromamassage. Once
a week for 8-10
weeks.

Diagnosis of
schizophrenia
or mental
retardation,
expected to be
transferred
from facility in
next 3 months.

6

Combination of
aromatherapy
and hand
massage vs.
aromatherapy
vs. placebo.
Administered
BID for 6
weeks.

Crossover
design:
Massage with
aromatherapy
then control vs.
control then
massage with
aromatherapy.
Three times a
week for 4
weeks with 4
week washout
interval.
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RESULTS
The three studies in this selective EBM review focused on adults over 60 with dementia
who exhibited symptoms of agitation. Yoshiyama et al. conducted a randomized single-blind
crossover study that included 14 participants with mild-to-moderate dementia living in a nursing
facility in Japan without acute physical illness.2 As evidenced by the study demographics, 100%
of the participants were female.2 They were randomly divided into two groups of seven, one
received control therapy, and the other received aromatherapy hand massage. The groups were
then switched after a four week washout period.2 The control consisted of jojoba oil, and the
aromatherapy oil was Delight & Harmony, a blend of essential oils. Each group received the
intervention three times per week for a four week period by a single aroma therapist. 2 A total of
3mL of oil was massaged on the participants hands one at a time starting with the forearm,
followed by the wrist, palm, fingers and back of the hand. The massage lasted 10 minutes and
was conducted in the living room of the nursing facility.2 The therapeutic interventions were not
performed if the participants had acute illness, infection or if they declined. The participants also
continued their medications as prescribed prior to commencement of the study. 2 The group that
received the control therapy first lost two participants due to acute physical illness and were not
accounted for in the final results.2
The outcomes were measured by a single researcher through the CMAI which was
conducted before and after the study as well as four weeks post-study.2 The results of the
authors’ analysis are presented as p-values summarized in Table 2 below. Both ‘complaining’
and ‘repetitious mannerisms’ decreased, however, did not show statistical significance with a pvalue of 0.75 and 0.5 respectively.2 In addition, the p-value in the follow up analysis did not
show significant change.2
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Table 2. CMAI p-Value Before and After Treatment2
CMAI
Complaining (verbally agitated
behavior)
Repetitious mannerisms
(physically nonaggressive
behavior)

p-Value before versus after
trials
0.75

p-Value before versus 4 wk
after trials
0.75

0.5

0.5

Fu et al. conducted a single-blinded randomized control trial including 67 participants
with a diagnosis of dementia from three long-term care homes in Australia.6 Patients who had a
diagnosis of schizophrenia or mental retardation, or expected to be transferred were excluded
from the study.6 Unlike the study authored by Yoshiyama et al., 41% of participants were male
and 59% were female.6 The participants were randomly placed into one of three groups
consisting of either aromatherapy with hand massage (n=19), aromatherapy alone (n=22), or
placebo with water spray (n=20).6 The intervention was administered twice a day for six weeks.6
Participants received a chest spray of either 3% lavender oil spray or water, if placed in the
control group. The aromatherapy with hand massage group additionally received a 5 minute hand
massage. All therapies were conducted in a private environement.6 One participant died in the
first week, and five other participants withdrew due to wanting to be involved in the treatment
group only. The results from these individuals were excluded in the analysis.6
Assessment of reduction in agitation with the administration of the CMAI was done
before, during and after the intervention by a facility staff member blind to the treatment groups.6
The CMAI short form (CMAI-SF) was measured five times throughout the study. Similar to the
study by Yoshiyama et al. while there was a decline in agitation symptoms it was not statistically
significant.6 The CMAI-SF mean score and standard deviation was reported and showed a
decline from the baseline in all areas except for ‘inappropriate dress or disrobing’.6 For example,
in the Agitation subscale depicted in Table 3 the average of the baseline mean is 2.65 compared
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to the post-test mean average of 2.18 which is a 17% reduction. The findings of all subscales are
summarized in Table 3 below. There was no specific p-value reported, however, the authors
mention there was no significant differences in participants mean scores for the CMAI across the
time periods measured.6
Table 3. CMAI-SF Mean Change from Baseline Across Five Points in Time6
CMAI
Nonaggression
Pace, aimless
wandering, etc.
General
restlessness, etc.
Inappropriate dress,
etc.
Handling things
inappropriately, etc.
Aggression
Cursing, etc.
Hitting, kicking,
biting, etc.
Grabbing people,
throwing, tearing,
etc.
Other or self-abuse,
etc.
Screaming, etc.
Agitation
Constant request
for attention, etc.
Repetitive
sentences, calls,
questions, etc.
Complaining,
negativism, etc.
Hiding & Holding
things, etc.

Baseline
Mean (SD)

Week 2
Mean (SD)

Week 4
Mean (SD)

Week 6
Mean (SD)

Post-test
Mean (SD)

2.48 (1.66)

2.30 (1.50)

2.38 (1.54)

2.33 (1.51)

2.18 (1.58)

3.07 (1.47)

2.61 (1.48)

2.48 (1.50)

2.41 (1.45)

2.28 (1.53)

1.74 (1.05)

1.79 (1.14)

1.67 (0.96)

1.77 (1.06)

1.77 (1.16)

2.0 (1.33)

1.80 (1.03)

1.79 (1.14)

1.75 (1.22)

1.56 (.98)

2.61 (1.28)
1.84 (1.07)

2.36 (1.17)
1.77 (1.01)

2.20 (1.21)
1.57 (0.97)

2.13 (1.23)
1.62 (0.90)

2.20 (1.15)
1.72 (1.02)

2.02 (1.23)

1.90 (1.12)

1.98 (1.27)

1.82 (1.04)

1.89 (1.07)

1.69 (1.04)

1.59 (1.02)

1.59 (1.02)

1.54 (1.03)

1.43 (0.87)

1.36 (0.93)

1.21 (0.76)

1.31 (0.74)

1.30 (.72)

1.28 (0.64)

2.38 (1.45)

2.20 (1.45)

2.21 (1.52)

1.98 (1.32)

2.0 (1.39)

2.82 (1.53)

2.56 (1.46)

2.49 (1.50)

2.34 (1.34)

2.41 (1.42)

2.75 (1.36)

2.38 (1.23)

2.25 (1.35)

2.03 (1.14)

2.13 (1.38)

2.08 (1.44)

1.74 (1.06)

1.59 (1.01)

1.67 (1.04)

1.69 (1.15)

Yang et al. conducted a cohort study comparing nonpharmacologic strategies to reduce
agitation symptoms in elderly patients with dementia.5 The participants were recruited from ten
long-term care facilities, and each facility was randomly assigned to one therapeutic
intervention.5 Participants were excluded if their behavior prevented interaction with researchers.
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Similarly to the first study reviewed by Yoshiyama et al. 65% of the participants were female. 5
This selective EBM review evaluates two of the interventions presented in the study,
reminiscence therapy and aroma-massage therapy. The study involved 102 patients with
dementia, 43 of which received 10 weeks of reminiscence therapy (RT) and 29 received 8 weeks
of aroma-massage therapy (AT).5 The selected therapies were administered once a week for the
duration of the study. Reminiscence therapy sessions were 50 minutes. The AT group received a
30 minute neck, shoulder, and arm massage with 100% pure Lavandula angustifolia and orange
oil once a week.5 The AT group lost 2 participants due to refusal, and the RT group lost 3 who
were all excluded from the analysis.
Assessment of the reduction in agitation was measured both pre- and post-study utilizing
the CMAI Chinese version. The analysis shows that aromatherapy was more effective at
reducing symptoms of agitation indicated by a p-value of <.001. Aromatherapy was more
effective at reducing the CMAI score with a mean change from baseline of 6.3 compared to RT
with a mean change from baseline of 0.21. Table 4 below summarizes the results.
Table 4. CMAI Mean Change From Baseline
CMAI-Chinese Version
Pretest
Posttest
Change

RT (n=40)
Mean (SD)
38.9 (10.1)
38.4 (12.2)
0.21 (6.6)

AT (n=27)
Mean (SD)
54.3 (16.7)
48.0 (18.6)
6.3 (11.0)

DISCUSSION
Dementia is a neurocognitive disorder that is evidenced by significant cognitive decline
and accompanied by behavioral and psychological symptoms like agitation. There are a number
of psychotropic medications that are used to manage these symptoms, all of which have adverse
effects especially in the elderly population. Due to this, nonpharmacologic interventions are
beneficial if they are successful in reduction of symptoms of agitation. This review evaluates the

FRINZI AROMATHERAPY MASSAGE

9

use of aromatherapy massage in reducing the symptoms of agitation indicated by a reduction in
the CMAI score. Aromatherapy massage has a number of benefits including increasing
oxygenation to tissues, releasing endorphins, and enhancing comfort all contributing to a
reduction in agitative behviors.5 An additional benefit to the use of aromatherapy, is that the
technique is easy to learn and employ in practice. Aromatherapy carries minimal adverse events
with allergic response being the most severe.
The three studied in this systemic review were conducted in nursing facilities, exclusion
criteria was similar with the exception of Yoshiyama et al. who only excluded patients with acute
physical illness while the others excluded additional psychologic disorders, like schizophrenia.
All studies performed allergic reaction testing or specified no allergies in the inclusion criteria.
Two studies compared aromatherapy oils to a placebo, and one compared aromatherapy to
reminiscence therapy. The studies in this review did not show significant reduction in symptoms
when compared to placebo, but when compared to other nonpharmacologic interventions
aromatherapy massage was more efficacious. Additionally, all three studies did show a decline in
behavioral symptoms of agitation. Despite the lack of statistical significance, the intervention
could be utilized on an individual basis if the particular patient receives a benefit. Some patients
withdrew from the studies due to the smell, which further shows the importance of
individualized response to aromatherapy in patients with dementia. All studies commented on
the evidence supporting the use of aromatherapy on an individual basis.2,5,6
There were limitations in all three studies. A shared limitation was not controlling the
medications patients were taking, specifically antipsychotics, which could have a drastic effect
on results. In the study by Fu et al., 45% of participants were on regular antipsychotic
medications6, and Yoshiyama et al. reported 17%.2 All studies could have benefited from a pre-
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study olfactory function test, as elderly patients can have some degree of sensory deficit. In Yang
et al., the interventions varied in dosage with the AT being the most individualized which could
have affected the results. In addition, the AT group had more patients with advanced dementia at
baseline compared to the RT group.5 As Yang et al. conducted a cohort study, a future RCT may
help to solidify the outcomes that AT was more efficacious in reducing symptoms of agitation
when compared to other nonpharmacologic interventions. An RCT authored by Fu et al. utilized
an aromatherapy spray, while other studies used the traditional method of massage oil which
may have led to the lack of statistical significance. A follow up study evaluating different types
of application may be beneficial to evaluate patient response to aromatherapy. A crossover style
RCT conducted by Yoshiyama et al. would have benefited from blind researchers and therapists.
This study could have also used a longer washout period. The generalizability of all of the
studies could have been improved with expanding to outside countries, inclusion of more male
participants, and larger sample sizes.
CONCLUSION
The evidence presented in this systematic EBM review showed that the use of
aromatherapy massage in reduction of agitation symptoms is inconclusive or conflicting. Yang et
al. found the use of aromatherapy to be statistically significant in reducing symptoms of agitation
with a mean decrease in CMAI score, but both Yoshiyama et al. and Fu et al. did not show
statistical significance. However, all three studies did show a decline in behavioral symptoms
from the use of aromatherapy massage. Considering the adverse effects of current pharmacologic
treatment, it would be beneficial to further explore this intervention as it is easy to learn and has
the ability to improve patient quality of life.
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Several issues with the studies in this review need to be addressed to further investigate
the benefit of aromatherapy massage. First, the different forms of aromatherapy interventions
must be explored. For example, essential oil concentration, type, and administration. Second, the
various types of dementia affecting the study outcome needs to be evaluated. Namely mild
versus severe dementia, and vascular compared to Alzheimer’s Dementia. Generalizability of
future studies can be improved with expanding research to different countries and across
multiple types of facilities. A future large scale randomized control trial is warranted to evaluate
the use of aromatherapy massage utilizing the same method of delivery and the same type of oil
with set dosage compared to a placebo. The future study would benefit from the use of blind
raters and therapists to avoid any potential bias.
Current studies are being conducted to compare the use of aromatherapy inhalation to
massage against a control group. The study sponsored by The Hong Kong Polytechnic
University commenced in November 2017 and aims to address the lack of research on comparing
the various applications of aromatherapy.8 The study is utilizing the Chinese version of the
CMAI as a primary outcome measure.8 The study was completed in October 2018, however,
results have not yet been published. Once published, the results of this study help to further
investigate the use of aromatherapy in elderly patients with dementia. Hopefully, further studies
show significance, and the technique of aromatherapy massage can be employed with efforts to
reduce agitation among elderly patients with dementia. This will not only improve patient quality
of life but will also aid caregivers in handling patients with this neurocognitive disorder.
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